Skip to main content
PeptiDex Logo

PeptiDex

Peptide Research Index

Research-backed

⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use

Privacy & Terms
Home
Library
StartToolsSaved
All Blends
🛡️

Thymosin Alpha-1 / BPC-157

"The Immune Fortress"

Thymosin Alpha-1BPC-157Immune Support

Benefits

Enhanced immunity, faster illness recovery, gut-immune axis support

Why This Blend?

Thymosin Alpha-1 supercharges immune cell function (T-cells, NK cells, dendritic cells), while BPC-157 heals the gut lining where 70% of the immune system resides. Attacking immune weakness from both sides.

Mechanism of Action

Tα1 enhances T-cell maturation, NK cell activity, and dendritic cell function for improved pathogen response. BPC-157 repairs gut mucosal integrity, supporting the gut-associated lymphoid tissue (GALT) — the body's largest immune organ.

Dosing Protocol

Typical Ratio: Thymosin Alpha-1 1.6mg + BPC-157 500mcg

Tα1 1.6mg SubQ 2x/week + BPC-157 250-500mcg SubQ daily. Cycle 8-24 weeks. Ideal during cold/flu season or post-illness.

Expected Timeline

Week 1

Immune activation; NK cell and T-cell enhancement begins

Weeks 2–4

Improved immune response; gut healing supports immune function

Months 2–3

Sustained immune modulation; reduced frequency of illness

Long-term

Long-term immune resilience; gut-immune axis restoration

Supporting Studies

Thymosin Alpha-1 safety and efficacy review

Review of 30+ clinical trials with 11,000+ subjects confirming safety and efficacy.

strong

BPC-157 gastrointestinal healing

BPC-157 heals GI ulcers and inflammatory bowel lesions.

preclinical

Safety Notes

Thymosin Alpha-1 approved in 35+ countries. Both peptides well-tolerated. Excellent safety profiles.

📚 Individual Peptide Profiles

Thymosin Alpha-1 →BPC-157 →